0001022079-20-000136.txt : 20200610 0001022079-20-000136.hdr.sgml : 20200610 20200610163300 ACCESSION NUMBER: 0001022079-20-000136 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200608 FILED AS OF DATE: 20200610 DATE AS OF CHANGE: 20200610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GUINAN MARK CENTRAL INDEX KEY: 0001505998 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 20955038 MAIL ADDRESS: STREET 1: C/O QUEST DIAGNOSTICS STREET 2: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 4 1 wf-form4_159182116205657.xml FORM 4 X0306 4 2020-06-08 0 0001022079 QUEST DIAGNOSTICS INC DGX 0001505998 GUINAN MARK 500 PLAZA DRIVE SECAUCUS NJ 07094 0 1 0 0 Executive Vice President & CFO Common Stock 2020-06-08 4 M 0 72596 71.17 A 146175 D Common Stock 2020-06-08 4 S 0 45826 116.811 D 100349 D Common Stock 2020-06-08 4 S 0 18246 117.649 D 82103 D Common Stock 2020-06-08 4 S 0 8524 118.604 D 73579 D Non-Qualifed Stock Option (right to buy) 71.17 2020-06-08 4 M 0 72596 71.17 D 2025-02-23 Common Stock 72596.0 0 D This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 6, 2020. This transaction was executed in multiple trades at prices ranging from $116.15 to $117.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $117.15 to $118.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $118.16 to $119.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The options vested in three annual installments beginning with the first on February 23, 2016, the second on February 23, 2017 and the final on February 23, 2018. /s/ William J. O'Shaughnessy, Jr., Attorney-in-Fact for Mark J. Guinan 2020-06-10